|
|
FAQ |
| 
|
|
|
The most frequently asked questions about Oridion technology, products and business models are found here. |
Oridion is a medical device company that has developed and patented unique technologies in the field of patient monitoring. The Company has sales activities in the US, Europe,Israel and the Far East. The Company employs 123 people worldwide. The Company headquarters are in Israel. Oridion was the first Israeli company to receive a CE mark (approval to self-certify) in the medical device field.
|
2. What is Oridion's core business?
|
|
Oridion is a global medical device company with patented technologies using breath samples in patient safety monitoring by developing proprietary medical devices and consumables for the measurement of carbon dioxide in human breath. Oridion capnography products determine the status and adequacy of a patient's ventilation, for all patient types and in all patient environments.
|
|
3. What is Oridion's potential business growth?
|
|
Oridion has designed its business line of patient safety monitors so that it can be used with all patients, both intubated and non-intubated in all environments, including procedural sedation, pain management and pre-hospital care. With the migration of procedures from the traditional operating theaters and intensive care units to surgical centers due to cost-containment efforts, technology development and new clinical standards, the trend towards procedural sedation monitoring is expected to result in double-digit growth rates.
Also, Oridion monitors are designed to use a single patient EtCO2 sampling line with each procedure. These proprietary EtCO2 sampling lines enable the use of the monitors in different clinical environments and are the self-sustaining engine that provides sales and gross margin growth as the installed base of monitors grow.
|
|
The technological edge offered by Microstream® technology has enabled Oridion to take its place as a market leader in capnography. Oridion has signed OEM development and distribution agreements with global leaders of monitoring systems including Physio, Philips Medical Systems, Draeger Medical (A Draeger and Siemens Company), Datascope, Covidien and more. These alliances will result in an increased installed base of capnography units supporting strong growth in the proprietary consumables business.
|
|
In many ways, Oridion does not have any competitors because of our unique, patented technology. Former technology competitors such as Philips Medical Systems have incorporated Oridion technology into their monitoring systems. Many of our previous competitors are today our partners or customers. |
|
Molecular Correlation Spectroscopy™ (marketed under the Microstream® trademark) is Oridion's patented fingerprinting technology. The patent is based on the fingerprinting of CO2 in exhaled breath. Employing this proprietary technology, the Company has made critical advances in the field of capnography monitoring. Oridion currently has over 40 registered patents, protecting the Company's technology used in the vital components of its products, in all of the Company's key markets including the U.S., Europe, Japan and Israel. In addition to its registered patents, Oridion has numerous patent applications pending worldwide. |
|
|
Copyright Oridion Systems Ltd. 2003-2009, info@oridion.com
Using this site means you accept the Terms of Use
|
|
|
